动物实验是新药研发中的重要一环,随着全球医药产业的快速发展,围绕动物实验环节也陆续衍生出了包括动物模型供应商、动物实验服务供应商等诸多企业。随着全球医药行业投融资环境趋于改善,身处产业链前端的国内动物实验相关企业是否已感知到需求的复苏?日前,药康生物(688046.SH)、南模生物(688265.SH)、昭衍新药(603127.SH)、美迪西(688202.SH)等动物实验产业链多家公司披露了三...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.